Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition

By  

Current Vascular Pharmacology, Vol. 15, Iss. 2, 2017-01 ,pp. : 96-102

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidinediones: Beyond Glycemic Control

By Reynolds Kathryn   Goldberg Ronald B.  

Treatments in Endocrinology, Vol. 5, Iss. 1, 2006-01 ,pp. : 25-36

Adis International

Access to resources Recommend Favorite

The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones

By Greenberg A.S.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 4, 2003-07 ,pp. : 218-228

Elsevier

Access to resources Recommend Favorite

Cardiovascular Disease Risk of Type 2 Diabetes Mellitus and Metabolic Syndrome: Focus on Aggressive Management of Dyslipidemia

By  

Current Diabetes Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 127-135

Bentham Science Publishers

Access to resources Recommend Favorite

Barriers to Achieving Optimal Glycemic Control in a Multi-Ethnic Society: A US Focus

By  

Current Diabetes Reviews, Vol. 2, Iss. 3, 2006-01 ,pp. : 285-293

Bentham Science Publishers

Access to resources Recommend Favorite